n-3 fatty acid supplementation was also associated with significant decreases in the levels of myeloperoxidase and lipoprotein-associated PLA2 as well as the suppression of tumorigenicity 2 (ST2), a marker of myocardial fibrosis [42]. This evidence concerns the gene MPO and Myocardial fibrosis.